Search results
Former Cork star Alan Cadogan says it’s time for GAA to introduce a TMO to avoid flashpoints
Irish Independent· 3 days agoFormer Cork hurler Alan Cadogan is adamant the GAA must experiment with using a television match...
Dylan Groenewegen wins stage six of Tour de France as Tadej Pogacar retains yellow jersey
Irish Independent· 3 days agoDutchman Dylan Groenewegen won the sixth stage of the Tour de France, a 163.5km ride from Macon, as he prevailed in a tight bunch sprint finish on Thursday. The Jayco AlUla rider, 31, let out ...
Fermanagh-Cavan Border to host innovative arts event 'Anything to Declare'
The Impartial Reporter via Yahoo News UK· 3 days agoThe Anything to Declare project is being delivered in two sections. Firstly, a creative artists...
French and UK Stocks Outshine European Peers Ahead of Elections
Bloomberg via Yahoo News UK· 3 days ago(Bloomberg) -- French stocks outperformed on Thursday, boosting the broader market, as polls showed...
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
Zacks via Yahoo Finance UK· 4 days agoRoche (RHHBY) announces that its mid to late-stage lung cancer study evaluating the tiragolumab...
What Chutatip ‘Nok’ Suntaranon Can’t Live Without
New York Magazine· 4 days ago“When I like something, I will get it in every color or version.”
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo Finance UK· 4 days agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
‘We have a strong preference now to stay within the county’ – Galway to seek internal appointment...
Irish Independent· 4 days agoGalway GAA chairman Paul Bellew said they wanted Henry Shefflin to stay in charge of the county’s...
‘We have a strong preference to stay within the county’ – Galway want internal appointment after...
Irish Independent· 4 days agoGalway GAA chairman Paul Bellew said they wanted Henry Shefflin to stay in charge of the county’s...
Roche to halt lung cancer trial
ShareCast· 4 days agoRoche is to end a novel lung cancer treatment trial, the Swiss company confirmed on Thursday, following "disappointing" results.